Jackson Jonathan 4
4 · Histogen Inc. · Filed May 28, 2020
Insider Transaction Report
Form 4
Histogen Inc.HSTO
Jackson Jonathan
Director10% Owner
Transactions
- Other
Common Stock
2020-05-26+2,356,597→ 2,356,597 total(indirect: See footnote)
Footnotes (2)
- [F1]Shares of common stock of the corporation formerly known as Histogen Inc. ("Histogen") were converted into shares of common stock of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of January 28, 2020, by and among the Issuer, Chinook Merger Sub, Inc. and Histogen (the "Merger Agreement"). Pursuant to the terms of the Merger Agreement, each share of Histogen common stock was exchanged for 1.4342 shares of the Issuer's common stock (the "Conversion"). Immediately following the merger, the Issuer changed its name to Histogen Inc. All share numbers reflect the one-for-ten reverse stock split (the "Reverse Split") effected by the Issuer immediately prior to the completion of the merger.
- [F2]Consists of shares held by Lordship Ventures ("Lordship"). Mr. Jackson is the Chairman of Lordship and has beneficial ownership over the securities owned by Lordship.